Pseudohypercalcemia and hyperviscosity with neurological manifestations in multiple myeloma.
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D001809:Blood Viscosity; D002330:Carmustine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D010243:Paralysis / Q000209:etiology / Q000628:therapy; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D012640:Seizures / Q000209:etiology / Q000628:therapy; D012712:Serum Globulins; D014750:Vincristine / Q000627:therapeutic use
D012712:Serum Globulins; D014750:Vincristine; D003520:Cyclophosphamide; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone